期刊文献+

不稳定型心绞痛患者甲状腺激素水平与冠状动脉病变的关系 被引量:4

The relationship study between plasma thyroid hormone in patients with unstable angina and the severity of coronary lesions
暂未订购
导出
摘要 目的探讨不稳定型心绞痛患者甲状腺激素水平与冠状动脉病变的关系。方法测定159例不稳定型心绞痛患者血浆游离三碘甲状腺原氨酸(FT3)、血浆游离甲状腺素(FT4)、血浆反三碘甲状腺原氨酸(rT3)和促甲状腺素(TSH)。根据冠脉病变记分分为轻、中、重三组,并与19例冠状动脉造影正常者对照,比较各组甲状腺激素水平,分析甲状腺激素水平与冠脉病变的相关性。结果159例不稳定型心绞痛患者中,重度冠状动脉病变组的血清FT3水平明显低于对照组(P<0.05),中、重度冠状动脉病变组的血清rT3水平均明显高于对照组(P<0.01)。血清FT3水平与冠状动脉病变记分呈负相关,r=-0.3942,P<0.01,血清rT3水平与冠状动脉病变记分呈正相关,r=0.4233,P<0.01。结论不稳定型心绞痛患者血清FT3水平降低,rT3水平升高,FT3和rT3的变化在一定程度上反映冠脉病变的严重性。 Objective To evaluate the relationship between plasma thyroid hormone in patients with unstable angina and the severity of coronary lesions. Methods Serum levels of thyroid hormones ( free triiodothyronine , reverse riiodothyronine , free thyroxine , and thyroid-stimulating hormone) were measured in 159 patients with unstable angina. All of the 159 patients were divided into three groups according the score of the coronary lesions. 19 patients with normal coronary as control group. Serum levels of thyroid hormones in all groups were compared, and the relationship between plasma thyroid hormone and the severity of coronary lesions were studied. Results The mean level of the hormone FT3 decreased in the group of severe coronary lesions compared with control group(P<0.05=, the rT3 levels increased in the groups of middle and severe lesions compared with control group(P<.001=. we found a strong negative corelation between FT3 and the score of the coronary lesions(r=-0.,3942,P<0.01=, a strong positive corelation between rT3 and the score of the coronary lesions(r=0.4233, P<0.01=. Conclusion The study suggested that the level of FT3 decreased and the level of rT3 increased in patient with unstable angina. The change of FT3 and rT3 could reflect the severity of coronary lesions.
出处 《中国心血管病研究》 CAS 2005年第2期122-124,共3页 Chinese Journal of Cardiovascular Research
关键词 甲状腺激素 冠状动脉疾病 不稳定型心绞痛 thyroid hormone coronary disease unstable angina,
  • 相关文献

参考文献8

  • 1[1]Friberg L, Drvota V, Bjelak AH, et al. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med.2001 , 111 (9): 699-703.
  • 2[2]Pavlou HN, Kliridis PA, Panagiotopoulos AA,et al. Euthyroid sick syndrome in acute ischemic syndromes. Angiology. 2002,53 (6): 699-707.
  • 3刘怀霖,刘颖,侯怀博,于力.冠心病心力衰竭患者血甲状腺激素的变化[J].临床心血管病杂志,1999,15(9):401-403. 被引量:10
  • 4[4]Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979,59: 607.
  • 5[5]Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am. 1995,79 (1):211-24. Review.
  • 6[7]Hamilton MA, Stevenson LW, Luu M, et al. Altered thyroid hormore metabolism in advanced heart failure. J Am Coll Cardiol, 1990, 16:91~95.
  • 7[8]Iervasi G, Pingitore A, Landi P,et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003 , 107(5) :708-13.
  • 8[9]Friberg L, Werner S, Eggertsen G, et al. Rapid downregulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002 Jun 24; 162(12): 1388-94.

二级参考文献1

  • 1Wibo M,Cardiol Res,1998年,37卷,151页

共引文献9

同被引文献28

  • 1唐浩熙,李介华,夏明凯,张小勇,李绍清,李冬秀,岑欢.超敏促甲状腺激素在糖尿病并发心肌梗死中的作用[J].中西医结合心脑血管病杂志,2005,3(4):306-307. 被引量:4
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2233
  • 3[3]Williams GH,Lilly LS,Seely EW.The heart in endocrine and nutritional disorders.In:Braunwald E,ed.HEART DISEASE-A textbook of cardiovascular medicine.5th ed.Philadelphia:W.B.Saunders Company,1997.1894-1895.
  • 4[4]Klein I,Ojamaa K.Thyroid hormone and the cardiovascular system.NEW Engl J Med,2001,344:501-509.
  • 5[5]Foley CM,McAllister RM,Hasser EM.Thyroid status influences baroreflex function and autonomic contributions to arterial pressure and heart rate.Am J Physiol Heart Circ Physiol,2001,280:H2061-H2068.
  • 6[6]Obuobie K,Smith J,Evans LM,et al.Increased central arterial stiffness in hypothyroidism.J Clin Endocrinol Metab,2002,87:4662-4666.
  • 7[7]Pirich C,Müllner M,Sinzinger H.Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants.Journal of Clinical Epidemiology,2000,53:623-629.
  • 8[8]Meier C,Staub JJ,Roth CB,et al.TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism:a double blind,placebo-controlled trial (basel thyroid study).J Clin Endocrinol Metab,2001,86:4860-4866.
  • 9Roos A,Bakker SJL,Links TP,et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects[J]. J Clin Endocrinol Metab,2007,92(2) :491-496.
  • 10Ochs N, Auer R, Bauer DC, et al. Meta analysis: subclinical thy roid dysfunction and the risk for coronary heart disease and mortality[J]. Ann Intern Med,2008,148(11) :832-845.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部